Medications for Hepatitis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatitis.
Found 11 Approved Drugs for Hepatitis
Baraclude
Generic Name
Entecavir
Baraclude
Generic Name
Entecavir
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: March 29, 2005
Classification: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. Entecavir is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. ( 1 )
Lamivudine
Brand Names
Cimduo, Combivir, Epzicom, Delstrigo, Dovato, SYMFI, Triumeq, Efavirenz, Abacavir, Epivir
Lamivudine
Brand Names
Cimduo, Combivir, Epzicom, Delstrigo, Dovato, SYMFI, Triumeq, Efavirenz, Abacavir, Epivir
Form: Tablet, Kit, Solution
Method of administration: Oral
FDA approval date: October 04, 2010
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), both nucleo(t)side reverse transcriptase inhibitors and are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. ( 1 )
Viread
Generic Name
Tenofovir Disoproxil
Viread
Generic Name
Tenofovir Disoproxil
Form: Tablet, Powder
Method of administration: Oral
FDA approval date: October 26, 2001
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older., Tenofovir disoproxil fumarate tablets are indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older.
Sofosbuvir
Brand Names
Sovaldi, Epclusa, Ledipasvir, Vosevi, Harvoni
Sofosbuvir
Brand Names
Sovaldi, Epclusa, Ledipasvir, Vosevi, Harvoni
Form: Pellet, Tablet
Method of administration: Oral
FDA approval date: December 06, 2013
Classification: Hepatitis C Virus NS5A Inhibitor
HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) [see Dosage and Administration.
Pegasys
Generic Name
PEGinterferon Alfa-2A
Pegasys
Generic Name
PEGinterferon Alfa-2A
Form: Injection
Method of administration: Subcutaneous
FDA approval date: October 16, 2002
Classification: Interferon alpha
PEGASYS is an inducer of the innate immune response indicated for the treatment of Chronic Hepatitis C (CHC).
Showing 1-5 of 11
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances